Public procurement notice: Contract Notice
Published: 2021-10-01
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33100000 | 33194110
Submission deadline: 2021-10-29
Award criteria: The most economic tender

Technical requirements: The contracting authority would like to enter into a framework agreement for a system for pain and symptom relieving treatment for Helse Midt-Norge RHF. Advance pain and symptom relieving treatment is given to patient groups for cancer and palliation (relieving treatment), both in hospitals and in the municipal health service. The pain and symptom relieving treatment can be given intravenously, via the spine, epidural, and subcutaneous via a syringe pump and/or a peristaltic pump.
Framework agreement for pumps for all relevant intravenous, subcutaneous, spinal, and epidural home treatment. The same pumps must also be suitable for use in hospitals. Municipal institutions will have an option to procure the pumps.
Pain and symptom relieving treatment can start in a hospital department and be continued at home or in a municipal institution. The treatment can also be started at home or in a municipal institution via a palliative team at the hospital, in cooperation with a GP and the home care service. Or it can be started in a municipal institution by a nursing home doctor, or in cooperation with the palliative team.
Continuation of the pain and symptom relieving treatment between hospital and the municipal health service means that it is expedient to use the same pumps in hospitals and in the municipal home service. The pumps that are used in the municipal health service are requisitioned from the Regional Unit for Treatment Aids (REB).
The estimated need for the specialist health service in Central Norway in the contract period will be approx.
200 syringe pumps and 250 peristaltic pumps. In addition the municipalities in central Norway can use the framework agreements an an option to procure their own pumps to use locally in the different units.
The estimated total value of both contracts, including options, will be between NOK 6,000,000 – 7,500,000 excluding VAT. Each sub-contract will make up approx. 50 % of the estimated total value. The contracting authority emphasises that the estimated volume/value is not binding for the contracting authority.
The total maximum value of both contracts will be  8,500,000, excluding VAT. Each sub-contract makes up
If the maximum value or the scope of the contract are exceeded before the end of the contract period, the contracting authority will have an exclusive right to terminate the contract completely or partially.
See Annex 2 -  'Requirements Specification' and Annex 3 - 'Price Sheet' for a more detailed description.
A framework agreement will be signed for 2 years, calculated from when it is signed. After that the contracting authority can extend the contract for up to 1+1 year at a time.
Pain and symptom relieving treatment can start in a hospital department and be continued at home or in a municipal institution. The treatment can also be started at home or in a municipal institution via a palliative team at the hospital, in cooperation with a GP and the home care service. Or it can be started in a municipal institution by a nursing home doctor, or in cooperation with the palliative team.
Continuation of the pain and symptom relieving treatment between hospital and the municipal health service means that it is expedient to use the same pumps in hospitals and in the municipal home service. The pumps that are used in the municipal health service are requisitioned from the Regional Unit for Treatment Aids (REB).
The estimated need for the specialist health service in Central Norway in the contract period will be approx.
200 syringe pumps and 250 peristaltic pumps. In addition the municipalities in central Norway can use the framework agreements an an option to procure their own pumps to use locally in the different units.